XPERIENCE is currently being evaluated in an independent, multicenter randomized controlled trial assessing its effect on the risk of periprosthetic joint infection following hip and knee replacement surgery. The trial is sponsored by the Ottawa Hospital Research Institute (ClinicalTrials.gov: NCT05543941).